Asthma Breakthrough

    
Back to Home Page

 

Edward M. Lichten, M.D., P.C.

180 East Brown Street

Birmingham, MI 48009

To make an appointment, phone: (248) 593-9999

 

LEARN ALL ABOUT your ANTI-AGING HORMONES
·Growth Hormone
 ·DHEA
 ·Testosterone
 ·Estradiol (women)
 ·Progesterone (women)
 ·Thyroid
 ·Cortisol
 ·Insulin

60 MORE PATIENT EDUCATION ARTICLES
·From Alzheimer's to Weight Loss

LINKS

 ·Drug benefit won't help care until overmedication declines

call 248.593.9999 to participate in this break-through ASTHMA treatment!

 OVERVIEW:  

Will Natural IV Vitamin Therapy Prove

to Be an Anti-Asthma Treatment?

More information to follow:

Short and long term treatment of asthma with intravenous nutrients
Nutrition Journal 2004, 3:6     doi:10.1186/1475-2891-3-6
Published   14 May 2004

Abstract

Background Asthma is an increasing problem in this country and others. Although medications for the treatment of asthma abound and are improving, there are inherent risks and side effects with all of them. Intravenous magnesium has been employed in the treatment of acute asthma, but its use has not become universal, nor has it been studied for the treatment of chronic asthma. It is known to be a safe drug with minimal side effects. In this study, the author investigates the use of magnesium and other nutrients in the treatment of both acute and chronic asthma.

Methods
In this non-blinded outcome study, following informed consent, forty-three (43) randomly selected volunteer patients with both acute and chronic asthma were treated with IV infusions described herein. All patients were observed with spirometry 10 minutes post-infusion; two sub-groups of patients were also observed after multiple infusions over a short period of time (less than one month) and a longer period of time (average 5.8 months). Pulmonary function was analyzed by spirometric testing with pre- and post-infusion spirometric measurements with the pre/post group. For longer term (Trend) patients, baseline spirometry measurements were compared to spirometry measurements after patients had received multiple infusions over a period of time. Eight (8) patients were measured for both pre/post and Trend data.

Results

The 38 pre-infusion/post-infusion patients with acute and chronic asthma demonstrated an overall average improvement (percentage improvement in percent predicted) of 45%. The 13 patients measured for improvement over time (Trend data, average duration 5.82 months), demonstrated an overall average improvement (percentage improvement in percent predicted) of 57%. Of the 13 patients in the multiple infusion group, 9 patients who received longer-term therapy (average duration of 12.58 months) for chronic asthma demonstrated an overall average improvement of 95% (percentage improvement in percent predicted).

Conclusion

The use of intravenous treatment with multiple nutrients, including magnesium, for acute and chronic asthma may be of considerable benefit. Pulmonary function improved progressively the longer patients received treatment.